StonvexLoading…
StonvexStonvexStonvexCore line items from OSPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $65.95M | $243.18M | $180.26M | $123.21M |
Operating Income | $14.82M | $48.45M | $35.91M | $27.69M |
Net Income | $11.56M | $72.90M | $29.36M | $8.34M |
EPS (Diluted) | $0.30 | $1.88 | $0.76 | $0.59 |
Total Assets | $383.15M | $397.70M | $343.52M | $357.10M |
Total Liabilities | $111.13M | $125.86M | $105.20M | $114.59M |
Cash & Equivalents | $49.75M | $70.50M | $85.55M | $92.89M |
Free Cash Flow OCF − CapEx | $25.05M | $50.49M | $40.87M | $32.10M |
Shares Outstanding | 36.98M | 37.36M | 37.95M | 38.25M |